Authors:
GOEDHALS L
HERON JF
KLEISBAUER JP
PAGANI O
SESSA C
GIGER K
CAVALLI F
LUDWIG C
AAPRO M
BLEIBERG H
DEWASH G
DICATO M
TAGNON A
VANSTRAELEN D
VINDEVOGHEL A
ABRATT R
FALKSON G
BARLEY V
CARMICHAEL J
COLEMAN R
DAVIDSON N
GRIEVE R
HARPER P
ROBERTS J
RUSTIN G
NAMAN H
SCHNEIDER M
NOBLE A
NETTER P
CUPISSOL D
BALMES P
CALS L
KHAYAT D
CATIMEL G
DUTIN JP
BOUFETTE P
ADENIS L
MISSET J
COLLERY P
NOUVET G
CHAVAILLON JM
BLANCHON F
POIRIER R
ARNAUD A
LECAER H
CARLES P
MUIR J
BONNAUD F
MARQUESTE L
CLAVIER J
GUERIN J
TAYTARD A
KEIZER H
NORTIER J
SLEE P
WILS J
RODENBURG C
BURGHOUTS J
DEWIT R
GARCIAGIRON C
JIMENEZLACAVE A
CRUZHERNANDEZ J
MASSUTISUREDA B
HANS K
FUCHS R
KRIEGMAIR M
SCHULLER J
LAHOUSEN M
PANNUTI F
MONFARDINI S
NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
Authors:
FALKSON G
GELMAN RS
PANDYA KJ
OSBORNE CK
TORMEY D
CUMMINGS FJ
SLEDGE GW
ABELOFF MD
Citation: G. Falkson et al., EASTERN-COOPERATIVE-ONCOLOGY-GROUP RANDOMIZED TRIALS OF OBSERVATION VERSUS MAINTENANCE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER IN COMPLETE REMISSION FOLLOWING INDUCTION TREATMENT, Journal of clinical oncology, 16(5), 1998, pp. 1669-1676
Authors:
DOMBERNOWSKY P
SMITH I
FALKSON G
LEONARD R
PANASCI L
BELLMUNT J
BEZWODA W
GARDIN G
GUDGEON A
MORGAN M
FORNASIERO A
HOFFMANN W
MICHEL J
HATSCHEK T
TJABBES T
CHAUDRI HA
HORNBERGER U
TRUNET PF
Citation: P. Dombernowsky et al., LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE, Journal of clinical oncology, 16(2), 1998, pp. 453-461
Authors:
MANSOUR EG
GRAY R
SHATILA AH
TORMEY DC
COOPER MR
OSBORNE CK
FALKSON G
Citation: Eg. Mansour et al., SURVIVAL ADVANTAGE OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - 10-YEAR ANALYSIS - AN INTERGROUP STUDY, Journal of clinical oncology, 16(11), 1998, pp. 3486-3492
Authors:
SLABBER CF
NEL JS
SCHOEMAN L
BURGER W
FALKSON G
FALKSON CI
Citation: Cf. Slabber et al., A RANDOMIZED STUDY OF RADIOTHERAPY ALONE VERSUS RADIOTHERAPY PLUS 5-FLUOROURACIL AND PLATINUM IN PATIENTS WITH INOPERABLE, LOCALLY ADVANCEDSQUAMOUS CANCER OF THE ESOPHAGUS, American journal of clinical oncology, 21(5), 1998, pp. 462-465
Authors:
CHANG AY
PUTT M
PANDYA KJ
HARRIS J
GELMAN R
TORMEY DC
FALKSON G
Citation: Ay. Chang et al., INDUCTION CHEMOTHERAPY OF DIBROMODULCITOL, ADRIAMYCIN(R), VINCRISTINE, TAMOXIFEN, AND HALOTESTIN(R) WITH METHOTREXATE IN METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E1181), American journal of clinical oncology, 21(1), 1998, pp. 99-104
Authors:
BEZWODA WR
GUDGEON A
FALKSON G
JORDAAN JP
GOEDHALS L
Citation: Wr. Bezwoda et al., FADROZOLE VERSUS MEGESTROL-ACETATE - A DOUBLE-BLIND RANDOMIZED TRIAL IN ADVANCED BREAST-CANCER, Oncology, 55(5), 1998, pp. 416-420
Authors:
DEJONGE ETM
FALKSON G
BURGER W
SCHOEMAN L
LINDEQUE BG
Citation: Etm. Dejonge et al., NEOADJUVANT CISPLATIN PLUS IFOSFAMIDE IN PATIENTS WITH STAGE IIB CERVICAL-CANCER - A SINGLE-CENTER PHASE-II STUDY, International journal of gynecological cancer, 7(2), 1997, pp. 158-162
Citation: M. Ribeiro et al., LOW SERUM TESTOSTERONE AND A YOUNGER AGE PREDICT FOR A POOR OUTCOME IN METASTATIC PROSTATE-CANCER, American journal of clinical oncology, 20(6), 1997, pp. 605-608
Authors:
OLSON JE
NEUBERG D
PANDYA KJ
RICHTER MP
SOLIN LJ
GILCHRIST KW
TORMEY DC
VEEDER M
FALKSON G
Citation: Je. Olson et al., THE ROLE OF RADIOTHERAPY IN THE MANAGEMENT OF OPERABLE LOCALLY ADVANCED BREAST-CARCINOMA - RESULTS OF A RANDOMIZED TRIAL BY THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP, Cancer, 79(6), 1997, pp. 1138-1149
Citation: Amlj. Hocepied et al., A PHASE-II TRIAL OF FLUDARABINE IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, South African medical journal, 86(5), 1996, pp. 549-550
Citation: Cf. Slabber et al., 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER - A PHASE-II TRIAL, Investigational new drugs, 14(4), 1996, pp. 391-394
Citation: Ci. Falkson et al., CISPLATIN VERSUS CISPLATIN PLUS D-TRP-6-LHRH IN THE TREATMENT OF OVARIAN-CANCER - A PILOT TRIAL TO INVESTIGATE THE EFFECT OF THE ADDITION OF A GNRH ANALOG TO CISPLATIN, Oncology, 53(4), 1996, pp. 313-317
Authors:
FALKSON G
HOLCROFT C
GELMAN RS
TORMEY DC
WOLTER JM
CUMMINGS FJ
Citation: G. Falkson et al., 10-YEAR FOLLOW-UP-STUDY OF PREMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(6), 1995, pp. 1453-1458
Authors:
FALKSON G
LIPSITZ S
BORDEN E
SIMSON I
HALLER D
Citation: G. Falkson et al., HEPATOCELLULAR-CARCINOMA - AN ECOG RANDOMIZED PHASE-II STUDY OF INTERFERON-BETA AND MENAGORIL, American journal of clinical oncology, 18(4), 1995, pp. 287-292
Authors:
GOEDHALS L
JORDAAN JP
KAYE SB
ARMAND JP
VEENHOF CHN
FALKSON G
SOUKOP M
SCHNEIDER M
OBERLING F
BUI BN
ROCHE H
ADENIS L
CATY A
BLIJHAM GH
DEWEWEIRE A
COIFFIER B
SOTTO JJ
VANHEUKELOM LS
TAGNON A
SLEE PHTJ
KROEKS MVAM
RAVEZ P
CUPISSOL D
KEIZER HJ
BRUNNER K
CALVERT AH
YERNAULT JC
LIBERT P
BROHEE D
Citation: L. Goedhals et al., A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Supportive care in cancer, 2(3), 1994, pp. 177-183
Authors:
ABRATT RP
BEZWODA WR
FALKSON G
GOEDHALS L
HACKING D
RUGG TA
Citation: Rp. Abratt et al., EFFICACY AND SAFETY PROFILE OF GEMCITABINE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 12(8), 1994, pp. 1535-1540
Authors:
BENNETT JM
TROXEL AB
GELMAN R
FALKSON G
DREICER R
TORMEY DC
RUSHING D
COCCIAPORTUGAL MD
Citation: Jm. Bennett et al., MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID-LEUKEMIA SECONDARY TO MITOLACTOL TREATMENT IN PATIENTS WITH BREAST-CANCER, Journal of clinical oncology, 12(4), 1994, pp. 874-875
Authors:
FALKSON G
GELMAN R
GLICK J
FALKSON CI
HARRIS J
Citation: G. Falkson et al., REINDUCTION WITH THE SAME CYTOSTATIC TREATMENT IN PATIENTS WITH METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(1), 1994, pp. 45-49
Citation: Ci. Falkson et al., PHASE-II TRIAL OF FOTEMUSTINE IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA, Investigational new drugs, 12(3), 1994, pp. 251-254